참고문헌
- Brase JC, Wuttig D, Kuner R, et al (2010). Serum microRNAs as non-invasive biomarker for cancer. Mol Cancer, 9, 306. https://doi.org/10.1186/1476-4598-9-306
- Cheng H, Zhang L, Cogdell DE, et al (2011). Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One, 6, e17745. https://doi.org/10.1371/journal.pone.0017745
- Criscitiello C, Sotiriou C, Ignatiadis M (2010). Circulating tumor cells and emerging blood biomarkers in breast cancer. Curr Opin Oncol, 22, 552-8. https://doi.org/10.1097/CCO.0b013e32833de186
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893- 917. https://doi.org/10.1002/ijc.25516
- Habbe N, Koorstra JB, Mendell JT, et al (2009). MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 8, 340-6. https://doi.org/10.4161/cbt.8.4.7338
- Hartgrink HH, Jansen EP, van Grieken NC, et al (2009). Gastric cancer. Lancet, 374, 477-90. https://doi.org/10.1016/S0140-6736(09)60617-6
- Hashimoto Y, Akiyama Y, Otsubo T, et al (2010). Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis, 31, 777-84. https://doi.org/10.1093/carcin/bgq013
- Jay C, Nemunaitis J, Chen P, et al (2007). miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol, 26, 293- 300. https://doi.org/10.1089/dna.2006.0554
- Ji X, Takahashi R, Hiura Y, et al (2009). Plasma miR208 as a biomarker of myocardial injury. Clin Chem, 55, 1944-9. https://doi.org/10.1373/clinchem.2009.125310
- Li BS, Zhao YL, Guo G, et al (2012). Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PloS One, 7, e41629. https://doi.org/10.1371/journal.pone.0041629
- Liu H, Zhu L, Liu B, et al (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett, 316, 196-203. https://doi.org/10.1016/j.canlet.2011.10.034
- Liu H, Zhu L, Liu B, et al (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett, 316, 196-203. https://doi.org/10.1016/j.canlet.2011.10.034
- Liu R, Zhang C, Hu Z, et al (2011). A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cance, 47, 784-91. https://doi.org/10.1016/j.ejca.2010.10.025
- Lowery AJ, Miller N, Devaney A, et al (2009). MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res, 11, R27. https://doi.org/10.1186/bcr2257
- Mattie MD, Benz CC, Bowers J, et al (2006). Optimized highthroughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer, 5, 24. https://doi.org/10.1186/1476-4598-5-24
- Mitchell PS, Parkin RK, Kroh EM, et al (2008). Circulating microRNAs as stable blood based markers for cancer detection. Proc Natl Acad Sci USA, 105, 10513-8. https://doi.org/10.1073/pnas.0804549105
- Ng EK, Chong WW, Jin H, et al (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-81. https://doi.org/10.1136/gut.2008.167817
- Osman A (2012). MicroRNAs in health and disease-basic science and clinical applications. Clin Lab, 58, 393-402.
- Resnick KE, Alder H, Hagan JP, et al (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real time PCR platform. Gynecol Oncol, 112, 55-9. https://doi.org/10.1016/j.ygyno.2008.08.036
- Slaby O, Lakomy R, Fadrus P, et al (2010). MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. Neoplasma, 57, 264-9. https://doi.org/10.4149/neo_2010_03_264
- Tsujiura M, Ichikawa D, Komatsu S, et al (2010). Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer, 102, 1174-9. https://doi.org/10.1038/sj.bjc.6605608
- Valadi H, Ekstrom K, Bossios A, et al (2007). Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 9, 654-9. https://doi.org/10.1038/ncb1596
- Wang F, Sun GP, Zou YF, et al (2012). MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark, 11, 259-67.
- Wong TS, Liu XB, Wong BY, et al (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res, 14, 2588-92. https://doi.org/10.1158/1078-0432.CCR-07-0666
- Yang N, Kaur S, Volinia S, et al (2008). MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res, 68, 10307-14. https://doi.org/10.1158/0008-5472.CAN-08-1954
피인용 문헌
- A potential regulatory loop between Lin28B:miR-212 in androgen-independent prostate cancer vol.45, pp.6, 2014, https://doi.org/10.3892/ijo.2014.2647
- Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo vol.12, pp.5, 2015, https://doi.org/10.3892/mmr.2015.4330
- Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma vol.26, pp.2, 2015, https://doi.org/10.1097/WNR.0000000000000302
- Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2273-6
- MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing’s sarcoma cells vol.18, pp.1, 2018, https://doi.org/10.1186/s12935-018-0536-9
- Decreased MicroRNA miR-181c Expression Associated with Gastric Cancer vol.49, pp.1, 2018, https://doi.org/10.1007/s12029-017-0042-7
- MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives vol.24, pp.30, 2018, https://doi.org/10.3748/wjg.v24.i30.3313